Burning Rock Biotech Limited
BNR
$8.83
-$0.46-4.95%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.65% | 1.71% | 2.33% | 4.56% | 4.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.65% | 1.71% | 2.33% | 4.56% | 4.56% |
| Cost of Revenue | -11.72% | -23.07% | -10.92% | -11.80% | -11.80% |
| Gross Profit | -15.73% | 11.85% | 7.64% | 12.19% | 12.19% |
| SG&A Expenses | 1.00% | -8.53% | -9.55% | -51.04% | -51.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.02% | -18.77% | -11.63% | -41.80% | -41.80% |
| Operating Income | -30.63% | 73.90% | 58.19% | 88.09% | 88.09% |
| Income Before Tax | -36.64% | 80.62% | 53.44% | 89.20% | 89.20% |
| Income Tax Expenses | 9.09% | -83.27% | 5.34% | 22.71% | 22.71% |
| Earnings from Continuing Operations | -36.18% | 80.79% | 53.11% | 89.04% | 89.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -36.18% | 80.79% | 53.11% | 89.04% | 89.04% |
| EBIT | -30.63% | 73.90% | 58.19% | 88.09% | 88.09% |
| EBITDA | -506.39% | 80.18% | 42.63% | 97.52% | 97.52% |
| EPS Basic | -39.30% | 81.05% | 55.08% | 89.55% | 89.55% |
| Normalized Basic EPS | -39.81% | 64.44% | 55.39% | 89.71% | 89.71% |
| EPS Diluted | -39.30% | 81.05% | 55.08% | 89.55% | 89.55% |
| Normalized Diluted EPS | -39.81% | 64.44% | 55.39% | 89.71% | 89.71% |
| Average Basic Shares Outstanding | -2.25% | 1.36% | 4.37% | 4.95% | 4.95% |
| Average Diluted Shares Outstanding | -2.25% | 1.35% | 4.38% | 4.94% | 4.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |